← Leaderboards
Austin J Barrett
Heart, Lung, And Blood Institute
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Heart, Lung, And Blood Institute
Same institution · by research overlap
Others in their field
Top investigators on “Leukemia”
- Richard K. Wilson · Washington University$209,620,938
- David Heimbrook · Leidos Biomedical Research, Inc.$168,419,678
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,967,203
- Peter C Adamson · National Childhood Cancer Foundation$143,910,899
- Ralph Parchment · Leidos Biomedical Research, Inc.$141,315,269
- Richard L Schilsky · University Of Chicago$129,102,207
Research focus
LeukemiaNatural Killer CellsT-LymphocyteRelapsePreventImmuneCellsStem Cell TransplantTransplantationStem CellsAllogenicCollaborationsResponseDoseNatural ImmunosuppressionAntigensPeptidesCd34 GeneGraft-Vs-Host DiseaseHematologic NeoplasmsProtocols DocumentationClinical TrialsRegimenRecovery
Grant awards (28)
improving outcomes after stem cell transplantation$1,496,532
ZIA · FY2017 · HL · contact PI
Characterization and improvement of graft versus leukemia effects$1,117,867
ZIA · FY2017 · HL · contact PI
Immunobiology and immunotherapy of leukemia$1,117,867
ZIA · FY2017 · HL · contact PI
improving outcomes after stem cell transplantation$1,432,613
ZIA · FY2016 · HL · contact PI
Characterization and improvement of graft versus leukemia effects$1,074,460
ZIA · FY2016 · HL · contact PI
Immunobiology and immunotherapy of leukemia$1,074,460
ZIA · FY2016 · HL · contact PI
improving outcomes after stem cell transplantation$1,283,329
ZIA · FY2015 · HL · contact PI
Characterization and improvement of graft versus leukemia effects$962,497
ZIA · FY2015 · HL · contact PI
Immunobiology and immunotherapy of leukemia$962,497
ZIA · FY2015 · HL · contact PI
improving outcomes after stem cell transplantation$1,805,115
ZIA · FY2014 · HL · contact PI
Characterization and improvement of graft versus leukemia effects$1,353,837
ZIA · FY2014 · HL · contact PI
Immunobiology and immunotherapy of leukemia$1,353,837
ZIA · FY2014 · HL · contact PI
improving outcomes after stem cell transplantation$1,784,136
ZIA · FY2013 · HL · contact PI
Immunobiology and immunotherapy of leukemia$1,339,575
ZIA · FY2013 · HL · contact PI
Characterization and improvement of graft versus leukemia effects$1,339,575
ZIA · FY2013 · HL · contact PI
improving outcomes after stem cell transplantation$1,966,744
ZIA · FY2012 · HL · contact PI
Characterization and improvement of graft versus leukemia effects$1,475,058
ZIA · FY2012 · HL · contact PI
Immunobiology and immunotherapy of leukemia$1,475,058
ZIA · FY2012 · HL · contact PI
improving outcomes after stem cell transplantation$1,690,370
ZIA · FY2011 · HL · contact PI
Characterization and improvement of graft versus leukemia effects$1,267,777
ZIA · FY2011 · HL · contact PI
Immunobiology and immunotherapy of leukemia$1,267,777
ZIA · FY2011 · HL · contact PI
Graft-versus-leukemia$3,273,957
ZIA · FY2010 · HL · contact PI
Graft-versus-leukemia$3,005,624
ZIA · FY2009 · HL · contact PI
Graft-versus-leukemia$3,884,898
Z01 · FY2008 · HL · contact PI
Graft-versus-leukemia$3,828,826
Z01 · FY2007 · HL · contact PI
Graft-versus-leukemia$0
Z01 · FY2006 · HL · contact PI
Graft-versus-leukemia$0
Z01 · FY2005 · HL
Graft-versus-leukemia$0
Z01 · FY2004 · HL